Endocrinology, Vol 131, 430-435, Copyright © 1992 by Endocrine Society

ARTICLES

Growth hormone and insulin-like growth factor-I increase macrophage uptake and degradation of low density lipoprotein

Z Hochberg, P Hertz, G Maor, J Oiknine and M Aviram
Department of Pediatrics, Rambam Medical Center, Haifa, Israel.

Hyperlipidemia has been reported in adults with hypopituitarism, and human (h) GH therapy has been shown to lower plasma cholesterol in patients with hypercholesterolemia. Macrophage cholesterol accumulation is an early event in atherosclerosis, and these cells have been shown to respond to GH and insulin-like growth factor (IGF-I). The present study was aimed at investigating the activity of GH and IGF-I in macrophages, and used murine macrophages as a model system to investigate the effects of GH and IGF-I on cellular uptake and metabolism of low density lipoprotein (LDL). The J-774 murine macrophage cell line was shown to bind hGH, to respond to hGH by an increase in cell IGF-I content, and to have specific high affinity binding sites for IGF-I. Mouse peritoneal macrophages and the J-774 macrophage cell line respond to hGH with a dose-dependent stimulation of cellular association and degradation of LDL as well as an enhanced cholesterol esterification rate. A similar response was observed after in vitro treatment of the cells with IGF-I. Preliminary results in human monocyte-derived macrophages showed similar results. The dependency of the effect of hGH on locally produced IGF-I was shown by abrogation of the hGH effect after adding anti-IGF-I antibody to the culture medium. It is concluded that murine macrophages possess the machinery to bind GH, produce IGF-I, and bind IGF-I. This machinery is used by macrophages, and apparently by other cells, to execute GH- dependent IGF-I-mediated stimulation of cellular uptake and metabolism of LDL. This may provide the explanation for both the elevated plasma LDL concentration in patients with GH deficiency and the effect of GH therapy to reduce plasma LDL levels.

This article has been cited by other articles:

				S. C. Harrington, R. D. Simari, and C. A. Conover Genetic Deletion of Pregnancy-Associated Plasma Protein-A Is Associated With Resistance to Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice Challenged With a High-Fat Diet Circ. Res., June 22, 2007; 100(12): 1696 - 1702. [Abstract] [Full Text] [PDF]

				J. Cosin-Sales, J. C. Kaski, M. Christiansen, P. Kaminski, C. Oxvig, M. T. Overgaard, D. Cole, and D. W. Holt Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris Eur. Heart J., October 2, 2005; 26(20): 2093 - 2098. [Abstract] [Full Text] [PDF]

				J. Cosin-Sales, M. Christiansen, P. Kaminski, C. Oxvig, M. T. Overgaard, D. Cole, D. W. Holt, and J. C. Kaski Pregnancy-Associated Plasma Protein A and Its Endogenous Inhibitor, the Proform of Eosinophil Major Basic Protein (proMBP), Are Related to Complex Stenosis Morphology in Patients With Stable Angina Pectoris Circulation, April 13, 2004; 109(14): 1724 - 1728. [Abstract] [Full Text] [PDF]

				A. Bayes-Genis, C. A. Conover, and R. S. Schwartz The Insulin-Like Growth Factor Axis : A Review of Atherosclerosis and Restenosis Circ. Res., February 4, 2000; 86(2): 125 - 130. [Abstract] [Full Text] [PDF]

				G. P. Ceda, E. Dall’Aglio, A. Magnacavallo, N. Vargas, V. Fontana, M. Maggio, G. Valenti, P. D. K. Lee, R. L. Hintz, and A. R. Hoffman The Insulin-Like Growth Factor Axis and Plasma Lipid Levels in the Elderly J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 499 - 502. [Abstract] [Full Text]

				R. Kooijman, A. Malur, S. C. van Buul-Offers, and E. L. Hooghe-Peters Growth Hormone Expression in Murine Bone Marrow Cells Is Independent of the Pituitary Transcription Factor Pit-1 Endocrinology, September 1, 1997; 138(9): 3949 - 3955. [Abstract] [Full Text] [PDF]

				H. Olivecrona, A. G. Johansson, E. Lindh, S. Ljunghall, L. Berglund, and B. Angelin Hormonal Regulation of Serum Lipoprotein(a) Levels : Contrasting Effects of Growth Hormone and Insulin-Like Growth Factor–I Arterioscler. Thromb. Vasc. Biol., July 1, 1995; 15(7): 847 - 849. [Abstract] [Full Text]

				K. J. Scheidegger, R. W. James, and P. Delafontaine Differential Effects of Low Density Lipoproteins on Insulin-like Growth Factor-1 (IGF-1) and IGF-1 Receptor Expression in Vascular Smooth Muscle Cells J. Biol. Chem., August 25, 2000; 275(35): 26864 - 26869. [Abstract] [Full Text] [PDF]